pH Associates' PCO team conduct a Delphi panel with expert UK Endocrinologists

pH Associates' Patient Centred Outcomes (PCO) team have successfully brought together expert UK endocrinologists and conducted a Delphi panel. The results of their Delphi panel has been published in Endocrine Abstracts, after being presented at the recent Society for Endocrinology, British Endocrinology Society (SfE, BES) 2017 meeting, in Harrogate.

This work was the first step to understanding the characteristics considered ‘important’ by UK hypoparathyroidism experts for defining patients with chronic hypoparathyroidism.

The results of the panel were recently presented at the Society for Endocrinology, British Endocrinology Society (SfE, BES) 2017 meeting, held in Harrogate and can be found at: Rylands et al. (2017). Delphi panel to define patients with chronic hypoparathyroidism ‘not adequately controlled on standard therapy’. Endocrine Abstracts, Volume 50, P062.

Catherine Bottomley and Angela Rylands are Management Consultants at pH Associates, a leading Real World Evidence (RWE) group and OPEN Health company. pH Associates have a growing team of expert PCO researchers who work alongside their core RWE team. For more information about Patient Centred Outcomes, please get in touch with Catherine and Angela at: CatherineBottomley@phassociates.com or AngelaRylands@phassociates.com.